The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy.
about
Principles in Management of Soft Tissue SarcomaLong-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trialTargeted therapy for cancer: the gastrointestinal stromal tumor model.Endoscopic full-thickness resection and laparoscopic surgery for treatment of gastric stromal tumors.Frequent KIT mutations in human gastrointestinal stromal tumors.Endoscopic full-thickness resection for gastric submucosal tumors arising from the muscularis propria layer.PDL1 expression is an independent prognostic factor in localized GIST.Gastrointestinal Stromal Tumors in Northeastern Iran: 46 Cases During 2003-2012.Endoscopic therapy for gastric stromal tumors originating from the muscularis propria.Genomic Grade Index predicts postoperative clinical outcome of GIST.Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors.Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients.Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor.A comparison of right posterior sectorectomy with formal right hepatectomy: a dual-institution study.Esophageal gastrointestinal stromal tumors presenting as mediastinal massKIT oncogene inhibition drives intratumoral macrophage M2 polarization.Retrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor.Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors.Gastrointestinal stromal tumors: who should get imatinib and for how long?Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors.Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumorsSurgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor.Sarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages.Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway.Sphincter sparing resection of a large obstructive distal rectal gastrointestinal stromal tumour after neoadjuvant therapy with imatinib (Glivec).GIST: advances in tyrosine kinase inhibitors enhance laparoscopic resection even in advanced disease.SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors.Clinicopathological and Prognostic Features of Surgical Management in Duodenal Gastrointestinal Stromal Tumors.Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor.PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.Long-term Results of Adjuvant Imatinib Treatment for Localized Gastrointestinal Stromal Tumors after SurgeryETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor.Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor.Molecular characterization of an Italian series of sporadic GISTs.[Translational research and diagnosis in GIST].Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis
P2860
Q26795619-19AF7B9D-85FA-4201-BB37-534B40293A1EQ33699901-C56D7781-7D82-49D8-914A-BDC800C7D509Q33807742-8E7BA9D5-ACD3-46B5-B9FB-6335438A8D47Q33845604-5073B1C8-1D8B-4227-A7DA-E88D35007695Q33985734-45ECD10D-A06E-4D84-8B54-CF93BBC418DAQ34326706-5115495F-26DE-448D-9E59-8FE3B88031F9Q35798839-7EC0814A-AEE0-4A13-B2E5-00D6595F540DQ36029559-B5680231-3B1C-4662-BD09-3FEF7A214224Q36093391-9B91EA8C-36F0-4218-AD43-BF796470F529Q36387916-E476B903-6FA9-4D5E-B91E-58AD4F869C19Q36577759-8035F1E4-F135-4B5D-985A-EA889865B5AEQ36627492-0A343AFB-C1F9-4E72-8CC2-35A4CC424EBCQ36979386-E0C2CEAD-57CC-417A-81BC-0E7011CD247DQ37216634-C0548E01-A86B-4819-90EB-250C9483F2B4Q37389277-1E3C4193-ED38-460B-BC24-06801C113D57Q37397817-9A3C24EF-75B6-43FE-B7FC-9708A524A045Q37705793-EA3A5F56-431D-464B-89D3-2EDB84FA8EA6Q38125536-01AD5569-EF2E-4575-9F9F-084C6461EC25Q38257940-DD7A8DA2-7015-4BC0-9739-85B72D9243CBQ38390024-949711FE-6AF0-4587-965B-1A33313E3859Q38891575-15DBAA03-A8D3-444E-A7C1-09CE8800EBC4Q39180294-B59F0A11-2BCA-4004-89E0-E9304EE8EBE5Q39394480-F2F21B71-47B7-4EAE-8D48-93A89974AA85Q40877796-1B1C007C-EC5B-41B5-AB99-D643DC408DB8Q42014039-D7E2A6E4-1D68-45FD-958F-8A8A13DE999FQ43100127-0419E5CA-5535-437C-AFBA-ACF48F7EDFA1Q45347250-B4A38918-5B92-45E5-A6D4-30A17DE937FDQ46498642-3B37C86F-5F91-4C5C-A58A-49477E6681ACQ47323711-18096F6E-6BE0-4B90-9F48-B9A5D17BEC17Q47679393-92C3BBEB-1F2E-41CB-BBCE-DAC3769289A6Q49150658-96C4896A-5D47-4B67-9456-262996FA2325Q49648852-3CF23AC6-5C7F-4536-BDBA-4AAE07F937C8Q49678212-ABB13DD2-B231-46CE-AA0F-83ED4034B65CQ50067311-F7493FE2-0133-4503-B7D3-EE3DE6019376Q50435067-ADEBC905-6292-487A-88DA-1F5547CA89A3Q54277025-54403C89-AAB4-4877-B922-2827A8F722D7Q54484634-4D95905D-265B-4F7B-A33D-403033376F01Q58762357-FE41EA94-64D8-468A-B00F-91F0F025B0BF
P2860
The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The management of gastrointest ...... plinary therapy of malignancy.
@en
The management of gastrointest ...... plinary therapy of malignancy.
@nl
type
label
The management of gastrointest ...... plinary therapy of malignancy.
@en
The management of gastrointest ...... plinary therapy of malignancy.
@nl
prefLabel
The management of gastrointest ...... plinary therapy of malignancy.
@en
The management of gastrointest ...... plinary therapy of malignancy.
@nl
P2860
P1476
The management of gastrointest ...... plinary therapy of malignancy.
@en
P2093
Ronald P DeMatteo
P2860
P304
P356
10.1146/ANNUREV-MED-043010-091813
P577
2011-10-13T00:00:00Z